-
Coronavirus Delta Variant Spreading Rapidly in the United States
drugs
June 24, 2021
The delta variant of the coronavirus that once crippled India now accounts for 20 percent of infections in the United States, Anthony Fauci, M.D., director of the U.S. National Institute of Allergy and Infectious Diseases, said Tuesday.
-
FDA to add warning about rare heart inflammation to Pfizer, Moderna vaccines
firstwordpharma
June 24, 2021
The FDA will add a warning about rare cases of heart inflammation in adolescents and young adults to fact sheets for the Pfizer/BioNTech and Moderna COVID-19 vaccines, as reported by the National Post.
-
Biopharmaceutical CEO Brussel meeting with EU leaders focuses on equitable access to tackle COVID-19, fostering innovation and unmet needs
firstwordpharma
June 23, 2021
The Biopharmaceutical CEO Roundtable (BCR) held their first face-to-face meeting since December 2019 in Brussels on Monday 21 and Tuesday 22 June, to discuss global health challenges and public health policies impacting biomedical innovation.
-
Putin Says Russia Continues Working on New Vaccines, Medication for Treating COVID-19
firstwordpharma
June 21, 2021
Russian President Vladimir Putin congratulated medical workers on Medical Worker Day, thanking them for their efforts in the fight against COVID-19 and calling for a more active vaccination programme, as reported Sputnik.
-
China's Sinopharm COVID-19 vaccines arrive in Thailand
firstwordpharma
June 21, 2021
A batch of Sinopharm COVID-19 vaccines landed in Bangkok on Sunday, as reported China Daily.
-
U.S. to Spend $3.2 Billion to Help Develop Antiviral Pills for COVID-19
drugs
June 21, 2021
After spending billions to speed the creation of COVID-19 vaccines, the United States said Thursday that it will now devote $3.2 billion to the development of antiviral pills that could stop the new coronavirus before it does its worst damage.
-
nference and Mayo Clinic Study Confirms No Significant Link Between Blood Clot Development and COVID-19 Vaccines
prnewswire
June 18, 2021
nference, the artificial intelligence (AI)-driven health technology company, today announced publication of a study in the Journal of Stroke and Cerebrovascular Diseases that analyzed Mayo Clinic health records with nference AI software
-
Houston Methodist Suspends Nearly 200 Workers Who Refuse COVID-19 Vaccines
drugs
June 11, 2021
Nearly 200 employees of the Houston Methodist hospital system in Texas have been suspended without pay for refusing to get COVID-19 vaccines.
-
Entegris to expand three life sciences manufacturing facilities
cphi-online
June 10, 2021
The expanded capacity and capabilities include the development of a dedicated Life Sciences Technology Center
-
COVID-19 Vaccine Patent Rules Reconsidered by World Trade Organization
drugs
June 09, 2021
A proposal to ease patents and related protections on COVID-19 vaccines in order to help developing nations fight the pandemic will be considered at a two-day meeting of a World Trade Organization (WTO) panel.